JOHNSON & JOHNSON |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.6 EUR | -1.62% |
|
-0.07% | -3.46% |
| 03/07 | Johnson & Johnson's Rybrevant Approved by Health Canada to Treat Advanced Lung Cancer | MT |
| 03/07 | Johnson & Johnson Lung Cancer Drug Gets Health Canada Approval | DJ |
5f895192757f3fe3d.sIOuN2PgUkt4qQiNTaUU3pGUh9tk0BKEyoqnDi6haAE.-_LKAzDUZSAi_FLrG-J-ms6h9ZkPsyXjic3DP13NCVv58MZvFZMrBjzqWQ~73d8b2ef4c8a939d82c0d98b712ce41a
